22. Moyamoya disease Clinical trials / Disease details

Clinical trials : 14 / Drugs : 21 - (DrugBank : 14) / Drug target genes : 28 - Drug target pathways : 44

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03882060 (ClinicalTrials.gov)	April 8, 2019	12/3/2019	Effect of Recombinant Human EPO on the Postoperative Neurologic Outcome in Pediatric Moyamoya Patients	The Effect of Recombinant Human Erythropoietin on the Postoperative Neurologic Outcome in Pediatric Moyamoya Disease Patients - A Double Blind Randomized Controlled Trial	Moyamoya Disease;Pediatrics;Cerebrovascular Disorders	Drug: erythropoietin;Drug: Normal saline	Seoul National University Hospital	NULL	Active, not recruiting	N/A	18 Years	All	60	N/A	Korea, Republic of
2	NCT03162588 (ClinicalTrials.gov)	May 1, 2010	18/5/2017	Multiple Burrhole Therapy With Erythropoietin for Unstable Moyamoya	Feasibility Study of Multiple Burrhole Therapy Combined With Intravenous Erythropoietin Pretreatment for Unstable Moyamoya	Ischemic Attack;Ischemic Stroke;Moyamoya Disease;Burr Hole;Angiogenesis	Drug: erythropoietin	Ajou University School of Medicine	NULL	Completed	16 Years	N/A	All	37	Phase 1/Phase 2	Korea, Republic of